Large‐scale proteomics to enable precision medicine for Alzheimer’s disease

Bart Smets, Asif Emon, Jon Greene, Pablo García‐González, Raquel Puerta, Alfredo Cabrera Socorro, Maarten Timmers, Agustin Ruiz, Christopher D Whelan · 2025

Read Large‐scale proteomics to enable precision medicine for Alzheimer’s disease by Bart Smets, Asif Emon, Jon Greene, Pablo García‐González, Raquel Puerta, Alfredo Cabrera Socorro, Maarten Timmers, Agustin Ruiz, Christopher D Whelan (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11716790.txt.

Description

Bart Smets and eight co-authors pool spinal fluid protein data to push Alzheimer's care toward precision medicine. Their 2025 study joins cohorts of neurodegenerative disease and reads thousands of proteins at once. The field already stages patients by amyloid, tau, and nerve damage markers; the team want the molecular story inside each stage.

One Spanish cohort of 1,321 people anchors the report. Survival models hunted proteins that predict the step from mild impairment to dementia, turning up fresh candidates beside known ones, among them MMP10. The work also confirms a three-subtype split found earlier: one marked by nerve plasticity proteins, one by innate immunity, and one by blood-related signals. Subtypes could one day match patients to the therapy most likely to help. More cohorts are being folded in.

Catalog record

CREATORBart Smets, Asif Emon, Jon Greene, Pablo García‐González, Raquel Puerta, Alfredo Cabrera Socorro, Maarten Timmers, Agustin Ruiz, Christopher D Whelan
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE3 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11716790

Browse the full library · About the Tower of Babel